Didanosine: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Didanosine. Educational only — not medical advice.
Labeled uses
Didanosine delayed-release capsules, also known as ddI, in combination with other antiretroviral agents is indicated for the treatment of human immunodeficiency virus (HIV)-1 infection [see Clinical Studies (14 ) ].
Source: FDA labeling via NIH DailyMed (set 829e744d…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.